Single-Time-Point Dosimetry of 177Lu-PSMA-617 Radionuclide Therapy with SPECT/CT

Radiol Imaging Cancer. 2023 Mar;5(2):e239006. doi: 10.1148/rycan.239006.
No abstract available

MeSH terms

  • Dipeptides* / therapeutic use
  • Heterocyclic Compounds, 1-Ring
  • Humans
  • Male
  • Prostate-Specific Antigen
  • Radioisotopes / therapeutic use
  • Single Photon Emission Computed Tomography Computed Tomography*

Substances

  • Dipeptides
  • Prostate-Specific Antigen
  • Radioisotopes
  • PSMA-617
  • Heterocyclic Compounds, 1-Ring